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INTRODUCTION
Arthropod-borne viruses (arboviruses) are responsible 
for numerous human infections worldwide, and cause 
both epidemics of serious disease as well as endemic 
disease in some areas. Despite documented evidence 
for their presence in virtually all African countries 
including Cameroon (1), they are almost never 
part of routine laboratory diagnoses and very often 
go unnoticed, probably accounting for morbidity 
and frequent debilitation. Arboviral infections 
indiscriminately manifest in humans with symptoms 
similar to those of malaria and typhoid fever, the most 
common causes of febrile illness in sub-Saharan Africa. 
The most common arboviral diseases of humans 
include dengue fever (DEN), yellow fever (YF) and 
chikungunya (CHIK). Dengue is characterised by 
fever, severe myalgia and arthralgia, and rash. Except 
for the painful symptoms, which led to the name 
“breakbrone fever,” classic DEN is a relatively mild 
disease and is usually not fatal (2). A more serious 
form of DEN, dengue haemorrhagic fever (DHF), is 
characterised by bleeding from the skin, gums, and 
gastrointestinal tract and sometimes by circulatory 
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ABSTRACT
Objectives: To investigate the silent circulation and transmission of arthropod-borne 
viruses (arboviruses) in the Fako Division of Cameroon. 
Design: This survey was conducted based on clinical observations and laboratory 
diagnosis; field collections of mosquitoes.
Setting: This study was conducted in the Fako Division of South West Cameroon.
Subjects: One hundred and two sera were obtained from febrile patients (with negative 
laboratory findings for malaria and typhoid fever) at clinics in the Fako Division, and 
diurnal anthropophilic mosquitoes (4,764) collected.
Interventions: Virus isolation was attempted from these, and sera were screened for 
antibodies against 18 African arboviruses by haemagglutination inhibition (HI) and 
complement fixation (CF) tests.
Results: No virus was isolated. Fifty three of 79 (67.1%) sera reacted with one or more 
viral antigens. Twenty nine sera (36.7%) reacted with members of the genus Alphavirus, 
with Chikungunya (CHIKV) and O’nyong-nyong (ONNV) viruses as the most frequent 
(34.2%). Forty six sera (58.2%) reacted with members of the genus Flavivirus: 24 (30.4%) 
were cross-reactive, but 11.4% reacted monotypically with Zika, 5.1% with yellow 
fever virus (YFV), 5.1% with dengue virus-2 (DENV-2), 2.5% with DENV-1 and 1.3% 
with Wesselsbron virus, respectively. The plaque reduction neutralisation test used 
to specify the agent that elicited the response could not resolve 33.3% of the cross 
reactions between CHIKV and ONNV. Neutralising antibody titres against ONNV 
and CHIKV were very high indicating probable re-infection. 
Conclusion: Our results indicate previously undetected circulation of arboviruses in 
Cameroon, and suggest that they are important, overlooked public health problems. 
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failure and shock (3,4). DEN is the fastest growing 
disease of the world with more than 2 billion people 
at risk, and the World Health Organization (WHO) 
estimates that “there may be 50 million cases of dengue 
infection worldwide every year” (4). Chikungunya 
is a dengue-like disease that can occur as a massive 
epidemic, as was the case in early 2006 on the French 
island of La Réunion (5). Yellow fever is caused by 
the yellow fever virus (YFV) and begins with fever, 
chills, headache, and backache, followed by nausea 
and vomiting, followed by a yellowing of the skin 
termed jaundice that gives the disease its name. In 
severe cases, the virus produces lesions in the infected 
organs, and haemorrhage occurs.
 These three arboviruses and many others are 
transmitted by diurnally active mosquitoes, mainly 
from the genus Aedes, even though some other groups 
may be important vectors. Numerous mosquitoes 
have been suspected and some incriminated as 
vectors of various arboviruses in Cameroon during 
the colonial and early postcolonial eras by surveys 
conducted by scientists from the Centre Pasteur and 
Office de la Recherche Scientifique et Technique Outre-
Mer (ORSTOM). Unfortunately, after the last (1976) 
publication of these surveys, there was a 25-year gap 
before Fontenille and Toto reported the introduction of 
the Aedes albopictus, a potential new vector of DF and 
YF into southern Cameroon (6-8). Later, Ndip et al. (9) 
Kuniholm et al. (10) and Demanou et al. (11), reported 
prevalence of antibodies (Abs) to some arboviruses 
in the serum of febrile patients in Cameroon, and 
Peyrefitte et al., isolated the CHIKV from a patient. 
In this survey, we sought to further investigate the 
latent circulation of arboviruses, characterise the 
agents and assess the risk of infection in Cameroon, 
with reference to the Fako Division (Figure 1). 
Figure 1
Map of the Fako division showing the locations of collection
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MATERIALS AND METHODS
Study population: One hundred and two sera were 
anonymously collected from consenting febrile 
patients (59 males and 43 females) consulting at the 
Provincial Hospital Annex and Mount Mary Health 
Centre in Buea, and the Cameroon Development 
Corporation Central Clinic, Tiko. These are the major 
settlements in the Fako division and comprise almost 
80% of the population. The hospitals in Buea and 
Tiko receive a very large number of patients from the 
region, with patients admitted from throughout the 
division. Laboratory diagnoses had excluded malaria 
and typhoid fever, the most common causes of fevers 
in Cameroon. Blood was collected in clean collection 
tubes, the serum separated and stored at -80oC. 
 Diurnally active anthropophilic mosquitoes 
(4,764) were obtained from human landing catches 
in Buea, Limbe and Tiko, by experienced collectors 
who were vaccinated against YF, received malaria 
medication, and had taken ivermectin to prevent 
onchocerciasis/river blindness.  All collections 
(serum and mosquitoes) strictly followed our protocol 
approved by the Ministry of Public Health and the 
administrations of the participating hospitals/clinics. 
Mosquitoes were equally stored at -80oC. All samples 
were transported on dry ice to the University of Texas 
Medical Branch (UTMB), Galveston, Texas, USA. 
 Virus isolation attempts: Although there was 
a conspicuous breach in the chain of cold during 
the transportation of the samples to the USA, virus 
isolation was nevertheless attempted (3). Mosquitoes 
were sorted on a chill table and pooled by species 
and by sex, homogenised in cell culture medium, 
centrifuged, filtered and 300 µL of each pool inoculated 
in a monolayer of mosquito (C6/36) and African 
green monkey kidney (Vero) cells. Human sera were 
inoculated directly into monolayers of Vero cells 
(300 µL) or diluted (1:10) and inoculated into C6/36  
cells. Cell cultures were incubated at appropriate 
temperature for 7 and 14 days respectively for C6/36 and 
Vero, and monitored daily for cytopathic effect (CPE). 
At the end of the incubation period, cells were harvested 
and screened by indirect immunofluorescence assay 
using mouse Abs against three members of the genus 
Flavivirus (YFV, DENV and ZIKAV). All virus isolation 
attempts were negative, possibly because of the rupture 
in the chain of cold, and are not further discussed in 
this paper. However, these failures and increasing 
difficulties in international transportation of diagnostic 
material stressed the need for the transfer of equipment 
(for appropriate containment) and diagnostic reagents 
to Cameroon. This is being properly addressed, and 
the development of high level biosafety containment 
facilities is underway. 
 Preparation of antigens: Arbovirus antigens (Ags) 
were obtained from the World Reference Collection for 
Emerging Viruses and Arboviruses (WRCEVA) at UTMB 
(Table 1). Prior to use in haemagglutination inhibition test 
(HI), Ags were titrated to determine optimal concentration 
(4 U used in test) and pH to use.
 Haemagglutination-inhibition tests: The sera 
were screened for the presence of Abs to African 
arboviruses. They were treated with acetone to remove 
lipids and non-specific inhibitors, and absorbed with 
goose cells to remove natural agglutinins. Titres were 
recorded as the highest dilution causing total or almost 
total inhibition of agglutination.
 Complement fixation: Complement fixation test 
(CF) was performed using 2 units of complement and 
some of the Ags previously prepared. The sera were 
incubated at 60oC for 20 minutes to inactivate naturally 
occurring human complement before testing (13). Titres 
were recorded as the highest dilution giving 3+ or 4+ 
fixation of complement on a scale of 0 to 4+.
 Plaque reduction neutralisation tests: Because some 
sera cross-reacted with multiple Ags (especially CHIK 
and ONNV), they were tested by the plaque reduction 
neutralisation test (PRNT) to discriminate between 
these infections. The Ross strain of the CHIKV and 
the MP730 strain of the ONNV obtained from the 
WRCEVA were amplified and titrated.  Each virus 
stock was diluted to a titre of 800 PFU/ml (plaque 
forming units per ml) and used in all assays. Serial 2-
fold dilutions of the 27 sera cross-reactive with CHIKV 
and ONNV were prepared, mixed with equal volumes 
of the virus stock, incubated at 4oC overnight and 
inoculated into monolayers of Vero cells. The cultures 
were then incubated until plaques formed. The titre 
of the neutralising Abs was considered as the highest 
dilution that would neutralise 80% or more of the 
virus in the stock used. Cross-reaction was resolved 
if there was a 4-fold or greater difference in the titre 
of the Abs to one of the viruses over the other.
RESULTS
Haemagglutination-inhibition: A total of 79 human sera 
was tested by HI for antibodies against 18 arthropod-
borne viruses. The results (Table 1) indicate that 53 (67.1 
%) sera reacted with one or more antigens. No evidence 
was found of immunity to viruses of the Orthobunyavirus, 
Phlebovirus or Thogotovirus genera. Twenty nine sera 
(36.7%) reacted with Alphavirus antigens, with CHIKV 
and ONNV as the most frequent (34.2%). Forty six sera 
(58.2%) reacted with Flavivirus antigens. Of this total, 
24 (30.4%) were cross-reactions, but four (5.1%) reacted 
monotypically with YF, nine (11.4%) with ZIKA, one 
(1.3%) with Wesselsbron (WSL) and two (2.5%) with 
a titre against YF and ZIKA, respectively, greater than 
with other Flavivirus antigens. In addition, four (5.1%) 
sera reacted with DEN-2 and two (2.5%) with DEN-1. 
 Complement fixation: Eighteen sera were studied using 
CF test and the presence of antibodies was confirmed in 
six sera reacting with CHIK and ONN antigens, six sera 
reacting with ZIKA among 10 HI positive, and one with 
SF (Table 2). These results indicate that most responses to 
ONNV were recent responses (titre ≥1:32). 
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Table 1
List of antigens used and prevalence of haemagglutination inhibition antibodies in sera from Cameroonian patients
Genus Antigen Number positive (%) Geometric mean titre
Alphavirus Chikungunya (CHIKV)  27 (34.2) 173
 Middleburg (MIDV) 21 (26.6) 35
 O’nyong nyong (ONNV) 27 (34.2) 179
 Semliki Forest (SFV) 21 (26.6) 41
 Sindbis (SINDV) 11 (13.9) 40
Flavivirus Dengue-1 (DENV-1)  30 (38.0)  76
 Dengue-2 (DENV-2) 31 (39.2) 100
 Dengue-3 (DENV-3) 28 (35.4) 49
 Dengue-4 (DENV-4) 28 (35.4) 66
 Spondweni (SPOV) 19 (24.1) 58
 Wesselbron (WSLV) 33 (41.8) 74
 West Nile (WNV) 27 (34.17) 49
 Yellow fever (YFV) 34 (43.03) 65
 Zika (ZIKAV) 30 (37.97) 101
Orthobunyavirus Ingwavuma (INGV) 0 0
 Tahyna (TAHV) 0 0
Phlebovirus Rift Valley (RVFV) 0 0
Thogotovirus Thogotovirus (THOV) 0 0
Table 2
Complement fixation test results
Sample ID
      Alphavirus      Flavivirus  
 ONN CHIK SF MID YF WSL ZIKA
2     16/≥32 16/≥32 
18       8/8(1:80)
22       0 (1:40)
46       0 (1:80)
47       16/8 (1:160)
50       32/8 (1:320)
51       32/8 (1:320)
59       0 (1:40)
65       0 (1:80)
77       16/8 (1:80)
78       16/8 (1:160)
5 32/≥32 32/8     
15 32/≥32 0     
37 64/≥32 8/8     
45 32/≥32 0     
52   16/≥32 0   
58 ≥256/≥32 0     
69 64/≥32 0     
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Numerator=titre of Ag used; denominator=titre of 
Ab used. Ab titre of 1:32 or more represents primary 
response; brackets indicate HI titre.
 Plaque reduction neutralisation test. The PRNT 
used to specify the agent that elicited the response 
could not resolve 33.3% of the cross reactions between 
CHIKV and ONNV (antibody titres were within 
2-fold), probably because both agents circulate in 
the study area. However, they clearly indicated that 
neutralising Ab titres against ONNV and CHIKV 
were generally very high, with 70% above 1:2560, 
indicating probable recent infections. In 48.1% of 
cases, neutralising Abs to ONNV had a titre at least 
4-fold higher than those for CHIKV, indicating that 
the response was mounted to an infection with the 
ONNV, while in 14.8% of sera, Abs to CHIKV were 
at least 4-fold higher (Figure 2).
Figure 2
Comparative chart of neutralising antibodies for CHIKV and ONNV
DISCUSSION
This research adds to the recent resumption of 
activities to monitor arbovirus circulation in 
Cameroon. The study of arboviruses in Cameroon 
was undertaken during the colonial era in the British 
part of the country then attached to the territory of 
Nigeria, and more extensively in the early years 
of independence of the country, mainly focusing 
around Yaoundé, the capital city. MacNamara 
reported the isolation the Kumba virus, which was 
ultimately recognised as a strain of the SFV (15), from 
Eretmapodites grahami mosquitoes. Joint teams from 
the Centre Pasteur du Cameroun and the ORSTOM 
continuously investigated the epidemiology, ecology 
and dynamics of arboviral transmission from 1963 
to the mid-1970s, including identification of vectors 
and potential reservoirs (16-19). Their investigations 
yielded among other major achievements the 
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discovery of three new viruses, Nkolbisson virus of the 
Rhabdoviridae, Okola virus of the family Bunyaviridae, 
and Yaoundé virus of the genus Flavivirus, as well as 
indicated that at least 23 arboviruses circulated in 
the forests of Cameroon (20). However, they found 
no evidence for the presence of any of the major 
human arboviruses known from other parts of 
Africa (16,19-24). 
 Our findings indicate that several arboviral 
infections of humans are probably endemic in 
Cameroon and that two or more arboviruses 
probably infect many people. This is especially true 
for infections with ZIKAV, ONNV and CHIKV, for 
which there is a relatively high prevalence of Abs and 
very high neutralisation titers (Figure 2).  Although 
these agents have never been, or are rarely isolated in 
Cameroon, the prevalence of the ONNV antibodies 
appears to be higher than that of the CHIK as had 
been observed in natural reservoirs (17). This may be 
accounted for by the fact that ONNV is transmitted 
by the malaria vectors (Anopheles spp.), which are 
certainly the most abundant African haematophagous 
insects. Posey and his collaborators (25) recently 
recorded an outbreak of ONNV in a refugee camp in 
Cote d’Ivoire and recommended laboratory diagnosis 
for arboviruses when massive outbreak of febrile rash 
illness occurs. CHIKV and ONNV are two closely 
related alphaviruses that are difficult to distinguish 
clinically or using serology, and for many years ONNV 
was considered by some investigators as a variant of 
CHIKV. Chikungunya, although not usually fatal, is 
a very painful and seriously debilitating disease. It 
recently caused an important epidemic on islands 
in the Indian Ocean (La Reunion, Comoros and 
Madagascar) with more than 300,000 cases reported, a 
major epidemic in India with up to 6.5 million cases, 
and also caused a small epidemic in Italy. Reports 
of fatalities and transmission from mother to child 
accompanied these epidemics (4). ZIKAV, which had 
not been previously reported in Cameroon, appears as 
the most important Flavivirus of humans in the Fako 
Division accounting for more than 11% of the fevers 
of unknown origin. It was found infecting patients 
in neighbouring Nigeria and causing an epidemic 
with symptoms including jaundice (26). Three of the 
patients having Abs to ZIKA in our study displayed 
jaundice, which was also seen in two patients with 
DENV-2 abs and one patient with YFV and WSLV. 
Yellow fever had not been reported from Cameroon 
since the last epidemics that affected the Adamawa 
highlands of the country and was poorly documented. 
The abs to YFV found in our study surely resulted 
from exposure to infectious mosquito bites because 
none of the positive patients had been vaccinated 
for YF. The data gathered in this survey enabled us 
determine that there was a high risk for an outbreak 
of YF in Fako, which was confirmed last September 
2009 with two confirmed cases of infection. There 
is now a national vaccination scheme for YF in the 
country and data suggest that between 72-87% of 
the population is now covered (27). The serotypes 
of DENV (-1 and -2) known to occur in Africa are 
also present in Cameroon. DENV-2 is on of the 
fastest spreading infectious agents in the world. Its 
importance in Cameroon is probably overlooked just 
like that of the other arboviruses because the area 
is endemic for malaria and typhoid fever for which 
diagnosis is readily available. Our findings generally 
corroborate those of recent studies in Cameroon (9,10). 
However, we have surprisingly not diagnosed any 
evidence of exposure to TAHV, which is relatively 
high in the study of Kuniholm and collaborators (10). 
This suggests more in-depth investigation to map the 
relative distribution of the various Arboviruses that 
circulate in the area. 
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